Valion Bio, Inc.
VBIO· Nasdaq
VBIOValion Bio, Inc.
Quarterly figures for Valion Bio, Inc., with source filings when available.
22 quarters. Mar 31, 2021 to Jun 30, 2026. USD.
Valion Bio, Inc. has filed its 10-Q within 44 to 45 days of period end across its last 8 quarters. The 10-K runs 80 to 90 days.
Valion Bio, Inc. · CIK 1787740 · Engraved from SEC EDGAR
| Mar 31, 2026 |
| May 14, 2026 · after-hours |
| May 14, 2026 |
| 44 d |
| 10-Q |
| — |
| — |
| — |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 25, 2026 · after-hours | Mar 30, 2026 | 89 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 · after-hours | Nov 14, 2025 | 45 d | 10-Q | $146.00K | +15.9% | — | |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 · after-hours | Aug 14, 2025 | 45 d | 10-Q | $86.00K | −38.6% | -$2.19 | |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 · after-hours | May 15, 2025 | 45 d | 10-Q | $70.00K | −79.0% | -$2.52 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 21, 2025 · after-hours | Mar 21, 2025 | 80 d | 10-K | $180.00K | −49.6% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 · after-hours | Nov 14, 2024 | 45 d | 10-Q | $126.00K | −55.3% | -$0.23 | |
| Q2 2024 | Jun 30, 2024 | Aug 14, 2024 · after-hours | Aug 14, 2024 | 45 d | 10-Q | $140.00K | −13.0% | -$5.37 | |
| Q1 2024 | Mar 31, 2024 | — | May 15, 2024 | 45 d | 10-Q | $334.00K | −11.2% | -$17.15 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 25, 2024 · after-hours | Mar 25, 2024 | 85 d | 10-K | $357.00K | −12.3% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 14, 2023 · after-hours | Nov 14, 2023 | 45 d | 10-Q | $282.00K | −40.9% | -$1.48 | |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 · after-hours | Aug 14, 2023 | 45 d | 10-Q | $161.00K | −69.5% | -$7.16 | |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 · after-hours | May 15, 2023 | 45 d | 10-Q | $376.00K | −12.1% | -$10.52 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 31, 2023 · market hours | Mar 31, 2023 | 90 d | 10-K | $407.00K | +4.6% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 · market hours | Nov 14, 2022 | 45 d | 10-Q | $477.00K | +72.2% | -$27.00 | |
| Q2 2022 | Jun 30, 2022 | Aug 15, 2022 · market hours | Aug 15, 2022 | 46 d | 10-Q | $528.00K | +97.0% | -$0.32 | |
| Q1 2022 | Mar 31, 2022 | May 16, 2022 · market hours | May 16, 2022 | 46 d | 10-Q | $428.00K | +32.5% | -$0.23 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | — | Mar 31, 2022 | 90 d | 10-K | $389.00K | — | — | |
| Q3 2021 | Sep 30, 2021 | — | — | — | — | $277.00K | — | -$0.90 | |
| Q2 2021 | Jun 30, 2021 | — | — | — | — | $268.00K | — | -$0.46 | |
| Q1 2021 | Mar 31, 2021 | — | — | — | — | $323.00K | — | -$0.58 | |
